|

Biologics targeting Type 2 inflammation Clinical Trials

1 actively recruiting trial

Also known as: Interventional group

Top Sponsors

  • Shanghai Pulmonary Hospital, Shanghai, China1

Indications

  • COPD - Chronic Obstructive Pulmonary Disease1
  • Asthma1
  • COPD1

Other1 trial

T2AIR: Real-World Efficacy and Safety of Biologics Targeting Type 2 Inflammation in Asthma and COPD

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.